Stayble Therapeutics receives approval to start Phase Ib clinical trial with STA363 for the treatment of herniated discs
Stayble Therapeutics AB ("Stayble" or the "Company") announces today that the Company has received approval to initiate the first clinical trial of its disc herniation candidate. The Company is broadening its activities by initiating a new project with STA363, targeting the indication lumbar disc herniation ("LDH"). A Phase 2b clinical trial is already underway in the indication degenerative disc disease ("DDD").The Phase 1b study will be conducted in Poland and carried out in collaboration with the contract research company Cromsource. The primary objective of the study is to evaluate
Elkem and Statkraft have signed a new long-term power agreement which secures additional competitive access to power for Elkem’s plant in Bremanger. The new contract covers a capacity of 20-40 MW for a duration of ten years.Elkem is already well-positioned with long-term power contracts in Norway, having secured more than 80 per cent of its electricity supply in the country at competitive rates. The new contract secures additional predictability for a total of 3 TWh in the period 2024-2033, supporting continued long-term operations and enabling new investments at the plant.
Elkem has
Paulig’s venture arm PINC has invested in the British startup WNWN, the first company to bring cocoa-free “chocolate” to market. The investment supports Paulig’s aim to develop a food culture that enables the well-being of people and the planet. WNWN’s technology is highly scalable, and the investment round will accelerate the company’s expansion.
Chocolate is one of the most beloved food products on the planet. The overall chocolate market is large and growing, in 2022, consumers globally consumed chocolate for 180 billion euros and the market is estimated to increase to 290
New research published in Nature Communications highlights the potential of using clean, abundant, advanced hydrogen-boron fuel in fusion energyFOOTHILL RANCH, Calif./ Lucerne, Switzerland. As fusion developers around the world race to commercialize fusion energy, TAE Technologies has pioneered the pursuit of the cleanest and most economical path to providing electricity with hydrogen boron (also known as p-B11 or p11B), an abundant, environmentally sound fuel. Today the company is announcing, in collaboration with Japan’s National Institute for Fusion Science
